Evidence map›Paper›PMID 32537663›Full record

ArticleChild's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery2020

Presenting symptoms in children with neurofibromatosis type 2.

Isabel Gugel, Florian Grimm, Christian Teuber, Julian Zipfel, Marcos Tatagiba, Victor-Felix Mautner, Martin Ulrich Schuhmann, Lan Kluwe

Open access · hybridAbstract read
In one paragraph

Article in Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Surgery in NF2-Schwannomatosis.Familial cancer · 2025
    Review
  2. Review
  3. Review
  4. Article
  5. Fits, Spots, Chunks and Nodules: An Unusual Diagnosis.Indian journal of pediatrics · 2024
    Article
  6. Observational
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Isabel GugelDepartment of Neurosurgery, University Hospital Tübingen, Tübingen, Germany. isabel.gugel@med.uni-tuebingen.de.ORCID http://orcid.org/0000-0003-2923-5949
Florian GrimmDepartment of Neurosurgery, University Hospital Tübingen, Tübingen, Germany.
Christian TeuberDepartment of Neurosurgery, University Hospital Tübingen, Tübingen, Germany.
Julian ZipfelDepartment of Neurosurgery, University Hospital Tübingen, Tübingen, Germany.
Marcos TatagibaDepartment of Neurosurgery, University Hospital Tübingen, Tübingen, Germany.
Victor-Felix MautnerCentre of Neurofibromatosis, Centre of Rare Disease, University Hospital Tübingen, Tübingen, Germany.
Martin Ulrich SchuhmannDepartment of Neurosurgery, University Hospital Tübingen, Tübingen, Germany.
Lan KluweDepartment of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
University Children's Hospital Tübingen · DEUniversität Hamburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe hallmark of neurofibromatosis type 2 (NF2) is the presence of bilateral vestibular schwannomas (VS) which however have not yet developed or grown to large size in children and young adolescents. Therefore, early diagnosis in pediatric patients without family history of NF2 has to be made by signs and symptoms not related to VS which will be reviewed in this study.

methodsA total of 70 children diagnosed for NF2 at an age of < 18 years were identified from our patient cohort. Age and symptoms, signs and pathology at symptom onset, age at NF2 diagnosis and symptoms leading to diagnosis as well as genetic findings were retrospectively reviewed.

resultsThe average age at symptom/sign onset was 8 ± 6 (range 0-17) years and 11 ± 5 (range 1-17) years at time of diagnosis. Fifteen children had a positive family history and were diagnosed upon additional clinical symptoms. The most frequent first presenting symptom/signs were ophthalmological abnormalities (49%), followed by cutaneous features (40%), non-VS-related neurological deficits (33%), and symptoms attributable to VS (21%). VS were not only the most common symptomatic neoplasm but also the most frequent pathological evidence for the diagnosis (72%). In 42 patients with available genetic testing results, pathogenic mutations were most frequently identified (n = 27).

conclusionThe presenting symptoms in NF2 children appear "unspecific" or less specific for classical NF2 compared with adult NF2 patients, posing a challenge particularly for cases without family history. In children, ophthalmological and cutaneous features should raise clinical suspicion for NF2 and referral to an NF2 specialized center is recommended.

Indexed as

Neurofibromatosis 2AdolescentAdultChildChild, PreschoolHumansInfantInfant, NewbornMutationRetrospective StudiesNeurofibromatosis type 2PediatricPresenting symptomVestibular schwannoma

Identifiers

PMID32537663
PMCPMC7575472
OpenAlexW3034474978

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.